| Jennifer W Niedfeldt, MD | |
|
575 West River Woods Parkway, Glendale, WI 53212 | |
| (414) 961-6700 | |
| (414) 961-6727 |
| Full Name | Jennifer W Niedfeldt |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 31 Years |
| Location | 575 West River Woods Parkway, Glendale, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215943451 | NPI | - | NPPES |
| 32310700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35679 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orthopaedic Hospital Of Wi | Glendale, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Hospital Of Wisconsin, Llc | 4981741709 | 22 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.
Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 9 days ago
| Entity Name | Glendale Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184648453 PECOS PAC ID: 0840262150 Enrollment ID: O20040809000098 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.
Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 9 days ago
| Entity Name | Orthopaedic Hospital Of Wisconsin, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669584983 PECOS PAC ID: 4981741709 Enrollment ID: O20160106001182 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.
Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer W Niedfeldt, MD 4555 West Schroeder Dr, Ste 170, Milwaukee, WI 53223 Ph: (414) 365-3210 | Jennifer W Niedfeldt, MD 575 West River Woods Parkway, Glendale, WI 53212 Ph: (414) 961-6700 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.
Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 9 days ago
Eugene P Sinclair, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 575 West River Woods Parkway, Glendale, WI 53212 Phone: 414-961-6700 Fax: 414-961-6727 | |
Mary T Breger, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7007 N Range Line Rd, Glendale, WI 53209 Phone: 414-352-3341 Fax: 414-247-4588 | |
Catherine C Mingo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7007 N Range Line Rd, Glendale, WI 53209 Phone: 414-352-3341 Fax: 414-247-4588 | |
Patrick M Cloud, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 575 West River Woods Pkwy, Glendale, WI 53212 Phone: 414-961-6700 Fax: 414-961-6727 | |
Maelynn D Colinco, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 North Range Line Road, Glendale, WI 53209 Phone: 414-352-3341 Fax: 414-247-4588 | |
James G Klamik, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 575 W River Woods Pkwy, Glendale, WI 53212 Phone: 414-961-6700 Fax: 414-961-6727 |